Workflow
辰欣药业(603367) - 2024 Q3 - 季度财报
CISENCISEN(SH:603367)2024-10-28 08:13

Financial Performance - The company's operating revenue for Q3 2024 was ¥931,725,795.30, a decrease of 5.90% compared to the same period last year[2] - The net profit attributable to shareholders was ¥127,802,143.29, an increase of 1.19% year-on-year[2] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥126,818,828.16, an increase of 9.52% compared to the same period last year[2] - Total operating revenue for the first three quarters of 2024 was CNY 3,002,250,189.03, a decrease of 6.5% compared to CNY 3,209,858,058.38 in the same period of 2023[16] - Net profit attributable to shareholders of the parent company for the first three quarters of 2024 was CNY 398,119,097.94, compared to CNY 390,446,788.08 in the same period of 2023, representing an increase of 2.0%[17] - The company reported a total comprehensive income of CNY 402,695,827.23 for the first three quarters of 2024, compared to CNY 392,107,499.16 in the same period of 2023, reflecting an increase of 2.0%[17] - Net profit for the first three quarters of 2024 was ¥310,779,841.23, down 2.1% from ¥318,443,351.42 in the first three quarters of 2023[25] Cash Flow and Investments - Cash flow from operating activities was ¥169,184,238.76, an increase of 8.82% year-on-year[2] - The total cash inflow from operating activities for the first three quarters of 2024 was approximately ¥2.77 billion, a decrease of 4.4% compared to ¥2.90 billion in the same period of 2023[18] - The net cash flow from operating activities for the first three quarters of 2024 was approximately ¥352.25 million, down from ¥371.17 million in 2023, reflecting a decline of 5.1%[19] - The cash outflow from investment activities for the first three quarters of 2024 was approximately ¥2.43 billion, a decrease of 18.0% compared to ¥2.96 billion in the same period of 2023[19] - The net cash flow from investment activities was negative at approximately -¥435.80 million for the first three quarters of 2024, compared to -¥330.20 million in 2023[19] - Cash inflow from investment activities was ¥2,000,898,008.50, down from ¥2,633,108,454.87 in the same period last year[26] - The cash outflow from investment activities totaled 2,444,318,021.47, down from 2,956,388,898.74, suggesting a decrease in investment expenditures[27] Assets and Liabilities - The total assets at the end of the reporting period were ¥7,476,484,611.62, an increase of 1.89% from the end of the previous year[3] - The total liabilities of the company amount to ¥1,504,313,055.96, compared to ¥1,369,920,021.79 at the end of 2023[13] - The total liabilities of the company as of the end of the third quarter of 2024 were CNY 1,605,993,064.25, compared to CNY 1,571,382,826.12 at the end of the same period in 2023, showing an increase of 2.0%[16] - The total current assets as of September 30, 2024, were approximately ¥4.16 billion, a decrease of 6.8% from ¥4.46 billion at the end of 2023[21] - The total assets as of September 30, 2024, were approximately ¥6.68 billion, a slight increase from ¥6.65 billion at the end of 2023[21] Shareholder Information - Total number of common shareholders at the end of the reporting period is 21,934[8] - The largest shareholder, Chenxin Technology Group Co., Ltd., holds 118,891,080 shares, representing 26.26% of total shares[10] - The company has a total of 5 shareholders holding more than 5% of shares, with the top 10 shareholders holding significant stakes[10] Research and Development - Research and development expenses for the first three quarters of 2024 amounted to CNY 272,306,294.13, an increase from CNY 255,417,050.30 in the same period of 2023, indicating a growth of 6.6%[16] - Research and development expenses increased to ¥233,071,532.55 in 2024, compared to ¥225,289,116.56 in 2023, reflecting a growth of 3.5%[24] - The company plans to continue focusing on R&D and market expansion strategies to enhance future growth prospects[24] Financial Position and Changes - The basic earnings per share for the reporting period was ¥0.28, unchanged from the previous year[3] - The weighted average return on equity was 2.11%, a decrease of 0.12 percentage points compared to the previous year[3] - The company reported a significant increase of 282.63% in other receivables, indicating an increase in other transactions during the reporting period[6] - The company’s deferred income tax liabilities increased to CNY 16,305,029.14 from CNY 12,677,059.44, indicating a rise of 28.5%[16] - The company has adopted new accounting standards starting in 2024, which may affect future financial reporting and performance metrics[27]